Osteogenic and angiogenic properties of heparin as a system of biomolecule delivery for bone bioengineering: a brief critical review

• Published in: Biomeditsinskaia khimiia Vol. 66; no. 6; p. 431
• Main Authors: Litvinova, L S, Yurova, K A, Khaziakhmatova, O G, Khlusova, M Yu, Malashchenko, V V, Shunkin, E O, Todosenko, N M, Norkin, I K, Ivanov, P A, Khlusov, I A
• Format: Journal Article
• Language: Russian
• Published: Russia (Federation) 01-11-2020
• Subjects: Bioengineering; Heparin; Mesenchymal Stem Cells; Osteogenesis; Tissue Engineering; bone tissue bioengineering; heparin; hemostasis system; delivery system; anticoagulant; regenerative medicine
• ISSN: 2310-6972
• DOI: 10.18097/PBMC20206606431

The review discusses the complex, ambiguous and individual effects of heparin and its derivatives on the bone and circulatory systems, in dependence of the dosage, the state of the cells and tissues of recipients. General data on the anticoagulant activity of heparin and its derivatives are presented; aspects of the effect of heparin on mesenchymal cells and tissues and its role in angiogenesis are considered in details. Particular attention is paid to the ability of heparin to bind osteogenic and angiogenic biomolecules: thus us especially important for the development of systems for their delivery and sustained controlled release. A schematic representation of the positive and side effects of heparin as a delivery system for biomolecules in tissue engineering is proposed.